16-4461790-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020677.6(NMRAL1):āc.890A>Cā(p.Asn297Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,611,978 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_020677.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NMRAL1 | NM_020677.6 | c.890A>C | p.Asn297Thr | missense_variant | 6/6 | ENST00000283429.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NMRAL1 | ENST00000283429.11 | c.890A>C | p.Asn297Thr | missense_variant | 6/6 | 1 | NM_020677.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152232Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000443 AC: 11AN: 248506Hom.: 0 AF XY: 0.0000446 AC XY: 6AN XY: 134404
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1459746Hom.: 0 Cov.: 32 AF XY: 0.0000124 AC XY: 9AN XY: 726236
GnomAD4 genome AF: 0.000118 AC: 18AN: 152232Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2023 | The c.890A>C (p.N297T) alteration is located in exon 6 (coding exon 5) of the NMRAL1 gene. This alteration results from a A to C substitution at nucleotide position 890, causing the asparagine (N) at amino acid position 297 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at